Anti-inflammatory Mechanisms Triggered by Apoptotic Cells during Their Clearance

In the human body, billions of cells die by apoptosis every day. The subsequent clearance of apoptotic cells by phagocytosis is normally efficient enough to prevent secondary necrosis and the consequent release of cell contents that would induce inflammation and trigger autoimmunity. In addition, ap...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 8; p. 909
Main Authors Szondy, Zsuzsa, Sarang, Zsolt, Kiss, Beáta, Garabuczi, Éva, Köröskényi, Krisztina
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 02.08.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:In the human body, billions of cells die by apoptosis every day. The subsequent clearance of apoptotic cells by phagocytosis is normally efficient enough to prevent secondary necrosis and the consequent release of cell contents that would induce inflammation and trigger autoimmunity. In addition, apoptotic cells generally induce an anti-inflammatory response, thus removal of apoptotic cells is usually immunologically silent. Since the first discovery that uptake of apoptotic cells leads to transforming growth factor (TGF)-β and interleukin (IL)-10 release by engulfing macrophages, numerous anti-inflammatory mechanisms triggered by apoptotic cells have been discovered, including release of anti-inflammatory molecules from the apoptotic cells, triggering immediate anti-inflammatory signaling pathways by apoptotic cell surface molecules phagocyte receptors, activating phagocyte nuclear receptors following uptake and inducing the production of anti-inflammatory soluble mediators by phagocytes that may act paracrine or autocrine mechanisms to amplify and preserve the anti-inflammatory state. Here, we summarize our present knowledge about how these anti-inflammatory mechanisms operate during the clearance of apoptotic cells.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Reviewed by: Sylvain Perruche, Institut national de la santé et de la recherche médicale, France; Patrizia Rovere Querini, Vita-Salute San Raffaele University, Italy
Specialty section: This article was submitted to Molecular Innate Immunity, a section of the journal Frontiers in Immunology
Edited by: Amiram Ariel, University of Haifa, Israel
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2017.00909